Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA
Pfizer has announced the first FDA-approved clinical drug trial involving all-electronic home-based reporting, according to a report in the Wall Street Journal. The drug being "tested", Detrol, is intended for use by patients with overactive bladders. However, the real purpose of the study, according to Pfizer, is to...
